Acute lymphoblastic leukaemia trials in South Korea

In South Korea 17 Also abroad 564

17 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 4Taking people
Asciminib Roll-over Study
Where
Busan, Jeollanam, Seoul, Uijeongbu-si
Age
7 years to 100 years
People
347 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00
Phase 1/2Taking people
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Where
Seoul
Age
6 months to 25 years
People
90 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00
Phase 1/2Taking people
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Where
Seoul
Age
16 years and over
People
85 worldwide
Run by
AstraZeneca
See details and how to joinNCT07155226 · EU 2025-521299-76-00
Phase 1/2Taking people
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
Where
Seoul
Age
12 years and over
People
83 worldwide
Run by
AstraZeneca
See details and how to joinNCT07109219 · EU 2025-522372-93-00
Phase 1/2Taking people
Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)
Where
Seoul
Age
1 year to 30 years
People
50 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07387926
Phase 1/2Taking people
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Where
Seoul
Age
12 years and over
People
255 worldwide
Run by
AstraZeneca
See details and how to joinNCT06137118 · EU 2023-505840-20-00
No phaseTaking people
Long-term Follow up Local Registry Study of Kymriah in South Korea
Where
Bundang Gu, Busan, Gyeonggi-do, Incheon, Jeollanam, Seongnam-si, Seoul, Ulsan
Age
0 years to 100 years
People
500
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06785818
Phase 2Taking people
Evaluation of Treatment Efficacy According to Risk Group in Relapsed Childhood Acute Lymphoblastic Leukemia
Where
Daegu, Daejeon, Hwasun, Jeju City, Seoul, Yangsan
Age
1 year to 22 years
People
90
Run by
Ho Joon Im
See details and how to joinNCT05827549
Phase 2Taking people
Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children
Where
Daegu, Daejeon, Hwasun, Jeju City, Seongnam, Seoul, Suwon, Yangsan
Age
1 year to 9 years
People
116
Run by
Hee Young Ju
See details and how to joinNCT06099366
Phase 2Taking people
Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia
Where
Incheon, Seoul, Suwon, Yangsan
Age
1 year to 19 years
People
370
Run by
Jae Wook Lee
See details and how to joinNCT06184009
Phase 2Taking people
Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea
Where
Daegu, Daejeon, Hwasun, Jeju City, Seoul, Yangsan
Age
1 year to 19 years
People
74
Run by
Hyoung Jin Kang
See details and how to joinNCT06257394
Phase 1/2Taking people
Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia Patients
Where
Seoul
Age
19 years and over
People
91
Run by
Curocell Inc.
See details and how to joinNCT04836507
Phase 3Taking people
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
Where
Busan, Seoul, Uijeongbu-si
Age
18 years and over
People
350 worldwide
Run by
Ascentage Pharma Group Inc.
See details and how to joinNCT06051409 · EU 2024-511496-14-00
Phase 1/2Taking people
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Where
Hwasun, Seoul
Age
12 years and over
People
606 worldwide
Run by
Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555
Phase 2Taking people
Venetoclax and Decitabine in R/R T-ALL
Where
Seongnam-si, Seoul
Age
19 years to 80 years
People
28
Run by
Seoul National University Hospital
See details and how to joinNCT06712121
No phaseTaking people
Multicenter Study on Rehabilitation Medical Data for Pediatric Big Brain Development
Where
Seongnam-si
Age
Up to 20 years
People
2,000
Run by
Bundang CHA Hospital
See details and how to joinNCT06367920
Phase 2Taking people
Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell Transplantation
Where
Seoul
Age
Up to 25 years
People
50
Run by
Seoul National University Hospital
See details and how to joinNCT06247501